HEAL's co-op student, Katelyn Janssen’s passion for research takes root

Co-ops prepare UC grad for career in laboratory research
Being in the lab full-time also gave Jansen the time to author and submit two abstracts to the American Association of Cancer Research conference, both of which were accepted. About a week prior to graduating on UC’s campus, Jansen was in Chicago presenting her work alongside cancer researchers from across the country — a rare accomplishment for an undergraduate student.

HEALing forward with Dr. Wise-Draper: Empowering anti-tumor immunity to transform HNC therapy

Immunotherapy inches forward in head and neck cancer trials
The University of Cincinnati Cancer Center's Trisha Wise-Draper was featured in a Targeted Therapies in Oncology article discussing the current state and future of immunotherapy trials to treat head and neck cancer.

Graduate Researcher, Shreya Shyamsunder, helps put lab in the spotlight with MSN feature on EGFR therapy resistance

Shreya Shyamsunder’s review on the challenges and resistance mechanisms to EGFR targeted therapies in head and neck cancers and breast cancer (Oncotarget, June 2025. PMID: 40560045) was highlighted in a  News Medical MSN article. 

 

Annual insight with lasting Impact: UC’s Head and Neck Disease Group launches the Head & Neck Cancer Scientific Retreat Series (May 2025). 

This annual event showcases the diverse head and neck cancer (HNC) research initiatives at the University of Cincinnati Cancer Center spanning basic, translational and clinical studies. The retreat serves as a platform for researchers and clinicians to collaborate, exchange ideas and advance HNC research. Additionally, industry and clinical sponsors are invited, offering investigators opportunities to engage with professionals across biomedical sectors—including clinical, diagnostic, and pharmaceutical fields—for networking and potential partnerships.